Skip to main content
. 2016 Jan 8;7(1):4–11. doi: 10.1007/s13340-015-0248-5

Table 3.

Proportion of patients who achieved the target values at baseline

Target n
(Men %)
All
n = 394 (%)
Men
n = 174 (%)
Women
n = 220 (%)
P values
HbA1c (%) <6 9 (55.6 %) 2.3 2.9 1.8 0.485
<7 99 (40.4 %) 25.3 23.1 26.9 0.387
<8 254 (42.5 %) 64.8 62.4 66.7 0.383
≧8 138 (47.1 %) 35.2 37.6 33.3 0.383
FPG (mg/dL) <130 96 (44.8 %) 59.4 46.5 69.8 0.021
PPPG (mg/dL) <180 344 (44.8 %) 58.7 61.0 56.8 0.432
BMI (kg/m2) 18 to <25 393 (44.3 %) 80.2  82.8 78.1  0.248
Blood pressure (mmHg) SBP < 130 and DBP < 80 389 (44.0 %) 55.8 57.9 54.1 0.458
LDL-C (mg/dL) <120 370 (43.2 %) 70.3 71.9 69.0 0.556
HDL-C (mg/dL) ≧40 388 (43.6 %) 97.9 95.3 100.0 0.001
non-HDL-C (mg/dL) <150 358 (43.0 %) 82.7 82.5 82.8 0.926
TG (mg/dL) <150 172 (40.7 %) 91.3 87.1 94.1 0.111

FPG fasting plasma glucose, PPPG postprandial plasma glucose, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, TG triglycerides

Numbers of the samples out of a total of 394 were shown in (N). HbA1c was measured in a total of 5924 subjects. TG was measured in the fasting state. All differences in frequency were tested for significance using χ 2 test. P values are given for sex differences, where a P value of 0.05 (two-sided) was considered to indicate significance